HIGHLIGHTS
- who: January and colleagues from the Zhejiang University City College, China have published the research: The quality of reporting of randomized controlled trials of HuatuoZaizao pill for stroke, in the Journal: (JOURNAL)
- what: The aim of this study is to evaluate the quality of the report of the RCTs of HZP in the treatment of stroke according to the CONSORT statement and the CONSORT-CHM statement.
SUMMARY
HZP treatment could promote functional recovery by enhancing the expression of brain-derived neurotrophic factor (BDNF) and increasing the level of neurogenesis in cerebral . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.